Manila Times Business
ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips MedisizeManufacturing capacity more than triples, with initial capacity to support over 17,000 usersVolume manufacturing drives gross margin expansion UTRECHT, The Netherlands, May 28, 2026 (GLOBE NEWSWIRE) -- ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced that commercial‑scale production of Kaleido consumables, including infusion sets an
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
1h ago
Ghana's 'anti-LGBTQ' law triggers both praise and outrage
2h ago
WHO chief visits epicentre of Ebola outbreak in DR Congo
2h ago
Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About
2h ago